NY State Informed Consent Tests - Mayo Clinic Laboratories
NY State Informed Consent Tests New York State clients are required by New York State regulations to have completed informed-consent forms on file. When ordering the following tests, all NYS clients are required to indicate to...
IMPACTS Team Continues to Combat Life-Threatening Arthropod-Borne Infections in Belize - Insights
Now in its second year of a five-year initiative to better understand and detect arboviruses in Belize, the IMPACTS (Integrated Mayo Clinic Program for Arbovirus Community health education Training and Surveillance) project has expanded its...
MCL Molecular Genetics Neurology Patient Information MC1235235
MCL Molecular Genetics Neurology Patient Information Complete print Molecular Genetics Neurology Patient Information Reset Form Instructions accurate interpretation reporting genetic results
Autoimmune Encephalitis Misdiagnosis - Insights
In this month's "Hot Topic," Eoin Flanagan, M.B., B. Ch., discusses the important issue of autoimmune encephalitis misdiagnosis and identifies red flags that be useful in clinical practice to suggest alternative diagnoses and highlight...
Frequently asked questions - Insights
Check out the answers to the most frequently asked questions about pharmacogenomic testing at Mayo Clinic Laboratories.
Precision oncology therapeutics - Insights
Learn more about our personalized cancer testing that establishes patients’ genetic profiles and allows physicians to select medications that optimize therapeutic efficacy while minimizing harmful reactions.
Inborn errors of metabolism - Insights
Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.
Myeloproliferative neoplasms - Insights
Learn about our reflexive molecular testing protocols that are designed to guide proper utilization of myeloproliferative neoplasms.
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights
Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.